BioScrip Company Profile (NASDAQ:BIOS)

Analyst Ratings

Consensus Ratings for BioScrip (NASDAQ:BIOS) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $3.00 (10.29% upside)

Analysts' Ratings History for BioScrip (NASDAQ:BIOS)
Show:
DateFirmActionRatingPrice TargetActions
3/5/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2015Dougherty & CoLower Price TargetBuy$7.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015SunTrust Banks Inc.DowngradeBuy -> Neutral$5.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Barrington ResearchReiterated RatingOutperform$7.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Jefferies GroupLower Price TargetBuy$8.00 -> $6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/9/2015Craig HallumInitiated CoverageBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for BioScrip (NASDAQ:BIOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2016Q1($0.12)($0.17)$232.38 million$238.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2016Q4($0.08)($0.13)$238.30 million$243.75 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.10)($0.38)$229.89 million$247.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.11)($3.60)$269.38 million$262.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.04)($0.17)$259.60 million$261.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2015Q414$0.01($0.69)$259.62 million$253.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314$0.02($0.42)$240.08 million$244.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214($0.02)($0.01)$233.70 million$247.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114($0.03)($0.13)$222.65 million$239.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q413$0.02$0.02$237.58 million$243.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013$0.04$0.13$206.47 million$190.73 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q1 2013$0.02$0.04$189.36 million$199.07 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2013Q4 2012$0.01$0.04$173.87 million$180.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.01)($0.01)$159.86 million$170.36 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2012($0.01)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2012($0.01)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2012$0.09$0.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2011$0.09$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2011$0.08$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.01)$0.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2011$0.04($1.25)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioScrip (NASDAQ:BIOS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.03)($0.03)($0.03)
Q4 20163($0.01)$0.01$0.00
Q1 20171($0.08)($0.08)($0.08)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.04)($0.04)($0.04)
Q4 20171$0.00$0.00$0.00
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioScrip (NASDAQ:BIOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioScrip (NASDAQ:BIOS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/22/2016Coliseum Capital Management, LDirectorBuy4,200,000$2.00$8,400,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2016David W GoldingDirectorBuy12,500$2.48$31,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Coliseum Capital Management, LDirectorBuy789,503$1.88$1,484,265.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Coliseum Capital Management, LDirectorBuy632,907$1.81$1,145,561.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015David W GoldingDirectorBuy20,000$1.54$30,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Richard M SmithCEOBuy5,000$4.27$21,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Yon JordenDirectorBuy5,000$3.47$17,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Myron Z HolubiakDirectorSell5,000$7.94$39,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Yon JordenDirectorBuy5,000$7.21$36,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Daniel ColucciVPSell18,500$12.40$229,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013David HubersDirectorSell11,200$12.23$136,976.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013Patricia BoguszVPSell39,687$11.94$473,862.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Kohlberg Management V, LlcInsiderSell6,895,873$13.00$89,646,349.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Myron Z HolubiakDirectorSell31,200$16.34$509,808.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2012Stuart A SamuelsDirectorSell11,200$9.66$108,192.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioScrip (NASDAQ:BIOS)
DateHeadline
07/26/16 10:26 AMPrice Target of $3.916 Set For BioScrip, Inc. (NASDAQ:BIOS) - RealistInvestor.com
07/26/16 07:06 AMBioScrip, Inc. breached its 50 day moving average in a Bullish Manner : BIOS-US : July 26, 2016 -
07/25/16 03:48 PMBioScrip To Host 2016 Second Quarter Results Call - [at noodls] - DENVER, July 25, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2016 second quarter financial results on Monday, August 8, 2016, before the opening ...
07/23/16 02:47 PMStock Focus: Following Analyst Expectations on Shares of BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
07/23/16 02:47 PMStock Displaying Signs of a Downtrend: BioScrip, Inc. (NASDAQ:BIOS) - Press Telegraph
07/21/16 08:25 PMBroker Outlook For BioScrip, Inc. (NASDAQ:BIOS) - Fiscal Standard
07/21/16 08:25 PMAccounts Payable For BioScrip, Inc. (NASDAQ:BIOS) Stood At $53.082 - RealistInvestor.com
07/19/16 02:51 PMHow Many BioScrip Inc (NASDAQ:BIOS)'s Analysts Are Bullish? - Consumer Eagle
07/19/16 02:51 PMBioScrip, Inc. (NASDAQ:BIOS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/19/16 02:51 PMBioScrip Inc versus Landauer Inc Head to Head Compare - CML News
07/19/16 09:01 AMTrading Performance and Target Watch for BioScrip, Inc. (NASDAQ:BIOS) - Press Telegraph
07/19/16 09:01 AMBioScrip, Inc. (NASDAQ:BIOS) Given $3.916 Price Target - RealistInvestor.com
07/19/16 09:01 AMWhat's The Growth Forecast For BioScrip, Inc. (NASDAQ:BIOS)? - RealistInvestor.com
07/15/16 07:05 PMShares Experiencing a Downtrend: BioScrip, Inc. (NASDAQ:BIOS) - TGP
07/13/16 10:55 AMAnalyst Target and Average Rating Watch: BioScrip, Inc. (NASDAQ:BIOS) - Press Telegraph
07/13/16 10:55 AMShares Losing Ground for the Month; Investor Alert on BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
07/12/16 02:54 PMBioScrip, Inc. (NASDAQ:BIOS) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 07:34 AM3 Reasons Growth Stock Investors Will Love BioScrip (BIOS) -
07/11/16 02:49 PMStock Volatility Focus for: BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
07/11/16 02:49 PMAre Analysts Bearish BioScrip Inc (NASDAQ:BIOS) After Last Week? - Consumer Eagle
07/11/16 02:49 PMBioScrip, Inc. (NASDAQ:BIOS)'s Growth Projection - RealistInvestor.com
07/10/16 02:46 PMBioScrip, Inc. (NASDAQ:BIOS) Awarded Price Target of $3.916 - RealistInvestor.com
07/08/16 02:51 PMBioScrip, Inc. versus USMD Holdings, Inc. Head to Head Compare - CML News
07/08/16 07:11 AMBioScrip, Inc. breached its 50 day moving average in a Bullish Manner : BIOS-US : July 8, 2016 -
07/06/16 08:39 PMIncreased Volatility Watch for: BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
07/06/16 08:39 PMQ1 2016 Sentiment Bioscrip Inc (NASDAQ:BIOS) - Engelwood Daily
07/06/16 08:39 PMForm 4 BioScrip, Inc. For: Jul 01 Filed by: Pate R Carter - StreetInsider.com
07/05/16 02:50 PMHC Stocks Outlines: BioScrip Inc (NASDAQ:BIOS), IDEXX Laboratories, Inc. (NASDAQ:IDXX) - share market updates (press release)
07/03/16 02:45 PMBioScrip, Inc. (NASDAQ:BIOS) Low Price Is Set At $2.75 - RealistInvestor.com
07/01/16 02:51 PMTracking Stock Volatility for: BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
07/01/16 02:51 PMBioScrip, Inc. (NASDAQ:BIOS) Updated Price Targets - FTSE News
06/30/16 08:18 PMInvestor News: Deadline upcoming in Settlement in the Lawsuit against BioScrip Inc (NASDAQ: BIOS)
06/30/16 10:44 AMInvestor News: Deadline upcoming in Settlement in the Lawsuit against BioScrip Inc (NASDAQ: BIOS) - GroundReport
06/29/16 11:07 AMBRIEF-North Tide Capital Master reports a passive stake of 7.5 pct in Bioscrip Inc
06/28/16 03:01 PMCheck on Share Volatility: BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
06/27/16 02:29 PMInsiders Are Buying These Shares: BioScrip Inc (NASDAQ:BIOS), Farmers National Banc Corp (NASDAQ:FMNB), IDI ... - iStreetWire
06/27/16 02:29 PMStock Volatility in Review: BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
06/27/16 07:31 AMColiseum Capital Adds To Its Stake In BioScrip Inc (BIOS) - Insider Monkey (blog)
06/26/16 02:30 PMColiseum Capital Adds To Its Stake In BioScrip Inc (BIOS) -
06/25/16 05:58 AMTraders Are Bearish BioScrip Inc After Today's Gap Down - Engelwood Daily
06/24/16 02:50 PMNew Broker Ratings For BioScrip, Inc. (NASDAQ:BIOS) - FTSE News
06/24/16 06:34 AMBioScrip Inc. (BIOS) is Trading Lower on Unusual Volume for June 22 - Equities.com
06/24/16 06:34 AMReview of Analysts Ranking: Stryker Corporation (NYSE:SYK) , BioScrip, Inc. (NASDAQ:BIOS) - Street Updates
06/23/16 10:16 PMBioScrip : Completes Public Offering of Common Stock
06/23/16 04:23 PMBioScrip Inc (NASDAQ:BIOS) & Pluristem Therapeutics (NASDAQ:PSTI) Healthcare Trader's Round Up - Wall Street 24
06/23/16 04:23 PMForm 8-K BioScrip, Inc. For: Jun 22 - StreetInsider.com
06/23/16 04:23 PMBioScrip Inc. (BIOS) is Trading Higher on Unusual Volume for June 21 - Equities.com
06/23/16 04:23 PMBioScrip, Inc. versus Concord Medical Services Holdings Limited Head to Head Compare - CML News
06/22/16 02:49 PMBioScrip, Inc. (NASDAQ:BIOS) Upside Stock Momentum at EXTREME Strength - CML News
06/22/16 09:52 AMBIOSCRIP, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -

Social

About BioScrip

BioScrip logoBioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates through approximately 70 service locations in over 30 states. The Company offers home infusion services to provide clinical management services and the delivery of prescription medications. The Company provides services in coordination with, and under the direction of, the patient's physician. The Company's multidisciplinary team of clinicians, including pharmacists, nurses, dietitians and respiratory therapists, work with the physician to develop a plan of care suited to the patient's specific needs. Its platform provides service capabilities to deliver clinical management services that offer patients a community-based and home-based care environment.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: BIOS
  • CUSIP: 09069N10
Key Metrics:
  • Previous Close: $2.72
  • 50 Day Moving Average: $2.60
  • 200 Day Moving Average: $2.29
  • P/E Ratio: N/A
  • P/E Growth: -1.07
  • Market Cap: $187.08M
  • Beta: 0.69
  • Current Year EPS Consensus Estimate: $-0.27 EPS
  • Next Year EPS Consensus Estimate: $-0.05 EPS
Additional Links:
BioScrip (NASDAQ:BIOS) Chart for Wednesday, July, 27, 2016